|
2023 |
2022 |
|||||||
|
Q2 |
Q1 |
Q2 |
||||||
Adjusted EBITDA (in millions) |
$ |
43.7 |
|
$ |
35.1 |
|
$ |
45.4 |
|
Divided by Total Net Sales (in millions) |
|
230.8 |
|
|
243.8 |
|
|
252.0 |
|
Adjusted EBITDA Margin |
|
18.9 |
% |
|
14.4 |
% |
|
18.0 |
% |
*Values in table may not add due to rounding. |
Reconciliation of net cash provided by (used in) operating activities to free cash flow*:
|
2023 |
2022 |
|||||||
(amounts in millions) |
Q2 |
Q1 |
Q2 |
||||||
Net cash provided by (used in) operating activities |
$ |
15.7 |
|
$ |
1.8 |
|
$ |
2.0 |
|
Non-acquisition capital expenditures |
|
(11.5 |
) |
|
(16.4 |
) |
|
(25.0 |
) |
Free cash flow |
$ |
4.2 |
|
$ |
(14.6 |
) |
$ |
(22.9 |
) |
*Values in table may not add due to rounding. Net cash provided by operating activities includes regulatory termination fee net of fees and taxes received in Q4 2022. |
Reconciliation of GAAP earnings per diluted share to adjusted earnings per diluted share guidance for the 2023 third quarter:
|
Guidance
|
| GAAP earnings per diluted share |
$1.20 to $1.40 |
|
|
|
| Discrete items* |
$(0.28) |
|
|
|
| Acquisition intangible amortization |
$0.13 |
|
|
|
| Adjusted earnings per diluted share |
$1.05 - $1.25 |
| *Discrete items includes expected net gain on assets held for sale |
